Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Genetic Mutation Analysis Market?
The genetic mutation analysis market size has experienced rapid expansion in recent years. Projections indicate it will expand from $5.94 billion in 2024 to $6.65 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.9%. Historical growth in this sector is primarily linked to the rising occurrence of genetic disorders and inherited diseases, increasing recognition of personalized medicine’s advantages, advancements in sequencing technologies, greater uptake of liquid biopsy techniques, and the expanding incorporation of AI and big data analytics.
The genetic mutation analysis market is projected to experience substantial growth in the coming years. It is forecast to expand to $10.30 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.5%. This anticipated growth during the forecast period stems from factors such as increasing government initiatives and funding for genomics research, a rising demand for early disease detection and preventive testing, expanding access to direct-to-consumer (DTC) genetic testing, heightened demand in oncology and infectious disease monitoring, and a greater emphasis on reproductive and prenatal genomic applications. Significant trends expected in this period include advancements in sequencing technologies, the integration of AI and bioinformatics tools, technological developments in rare mutation detection, progress in lab-on-a-chip and microfluidics, and the incorporation of accelerated computing.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp
Which Drivers Are Shaping The Genetic Mutation Analysis Industry’s Market Share?
The growing incidence of genetic disorders is anticipated to fuel the expansion of the genetic mutation analysis market. These disorders, defined as conditions arising from abnormalities or mutations in an individual’s DNA, can be either inherited or occur spontaneously. A contributing factor to their increased prevalence is advanced parental age, which elevates the risk of genetic mutations during reproduction, consequently leading to a higher probability of these disorders in offspring. Genetic mutation analysis plays a crucial role by detecting gene changes that indicate or cause genetic disorders, thereby enabling early diagnosis, precise treatment, and informed decisions regarding reproduction or lifestyle. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity, reported that cystic fibrosis patient registrations rose from 11,148 in 2022 to 11,318 in 2023, representing a 1.5% increase year-over-year. This upward trend in genetic disorder prevalence is therefore a significant driver for the genetic mutation analysis market.
What Are The Different Segment Classifications Within The Genetic Mutation Analysis Market?
The genetic mutation analysis market covered in this report is segmented
1) By Component: Hardware, Software, Services
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories
Subsegment:
1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems
2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools
3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services
What Trends Are Redefining The Genetic Mutation Analysis Market Dynamics?
Leading companies in the genetic mutation analysis market are concentrating on developing innovative solutions, such as tissue-based next-generation sequencing (NGS) tests, to enhance the precision of identifying actionable genetic alterations and guiding personalized treatment strategies. Tissue-based next-generation sequencing (NGS) tests are sophisticated diagnostic tools that analyze DNA or RNA from a tissue sample to detect genetic mutations, alterations, or biomarkers associated with diseases like cancer. For instance, in June 2024, Guardant Health Inc., a US-based oncology company, launched the Guardant360 TissueNext test, expanding the number of genes it identifies in a tumor tissue sample to 498. These genes, or cancer biomarkers, allow oncologists to identify the most effective targeted therapies or treatment strategies for patients with advanced cancer. In addition to the panel expansion, Guardant has improved the test’s operational workflow for a faster turnaround time. The new Guardant360 TissueNext test will be covered for Medicare fee-for-service patients with advanced solid tumor cancers as a standalone service, based on coverage conveyed by Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), under the existing local coverage determination.
Which Major Firms Are Strengthening Their Position In The Genetic Mutation Analysis Industry?
Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, and BGI Genomics Co. Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/genetic-mutation-analysis-global-market-report
How Is Genetic Mutation Analysis Market Demand Varying Across Different Regions?
North America was the largest region in the genetic mutation analysis market in 2024. The regions covered in the genetic mutation analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Genetic Mutation Analysis Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27297&type=smp
Browse Through More Reports Similar to the Global Genetic Mutation Analysis Market 2025, By The Business Research Company
Mining Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mining-equipment-global-market-report
Electric Mining Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/electric-mining-equipment-global-market-report
Autonomous Mining Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autonomous-mining-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model